Article Details
Retrieved on: 2022-01-01 03:38:52
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The biotechnology company reported ($0.24) EPS for the quarter, beating the Zacks' consensus estimate of ($0.85) by $0.61.
Article found on: etfdailynews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here